Up-regulation of c-FLIPS+R upon CD40 stimulation is associated with inhibition of CD95-induced apoptosis in primary precursor B-ALL.

Standard

Up-regulation of c-FLIPS+R upon CD40 stimulation is associated with inhibition of CD95-induced apoptosis in primary precursor B-ALL. / Troeger, Anja; Schmitz, Ingo; Siepermann, Meinolf; Glouchkova, Ludmila; Gerdemann, Ulrike; Janka-Schaub, Gritta; Schulze-Osthoff, Klaus; Dilloo, Dagmar.

in: BLOOD, Jahrgang 110, Nr. 1, 1, 2007, S. 384-387.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Troeger, A, Schmitz, I, Siepermann, M, Glouchkova, L, Gerdemann, U, Janka-Schaub, G, Schulze-Osthoff, K & Dilloo, D 2007, 'Up-regulation of c-FLIPS+R upon CD40 stimulation is associated with inhibition of CD95-induced apoptosis in primary precursor B-ALL.', BLOOD, Jg. 110, Nr. 1, 1, S. 384-387. <http://www.ncbi.nlm.nih.gov/pubmed/17376892?dopt=Citation>

APA

Troeger, A., Schmitz, I., Siepermann, M., Glouchkova, L., Gerdemann, U., Janka-Schaub, G., Schulze-Osthoff, K., & Dilloo, D. (2007). Up-regulation of c-FLIPS+R upon CD40 stimulation is associated with inhibition of CD95-induced apoptosis in primary precursor B-ALL. BLOOD, 110(1), 384-387. [1]. http://www.ncbi.nlm.nih.gov/pubmed/17376892?dopt=Citation

Vancouver

Troeger A, Schmitz I, Siepermann M, Glouchkova L, Gerdemann U, Janka-Schaub G et al. Up-regulation of c-FLIPS+R upon CD40 stimulation is associated with inhibition of CD95-induced apoptosis in primary precursor B-ALL. BLOOD. 2007;110(1):384-387. 1.

Bibtex

@article{62ef4ebbf3074ef4a68d1c2d51c39001,
title = "Up-regulation of c-FLIPS+R upon CD40 stimulation is associated with inhibition of CD95-induced apoptosis in primary precursor B-ALL.",
abstract = "Previous studies on apoptosis defects in acute lymphoblastic leukemia (ALL) have focused on chemotherapy-induced, primarily mitochondrial death pathways. Yet, immunologic surveillance mechanisms including sensitization to apoptotic signals mediated via the death receptor CD95 might contribute to leukemic control. Here, we show that primary B-cell precursor ALL cells from children escape from receptor-dependent cell death in 2 ways: Resting ALL blasts are protected from receptor-mediated apoptosis due to the absence of CD95 surface expression. However, even though CD40 ligation results in up-regulation of CD95, ALL blasts, unlike normal B cells, remain resistant to apoptosis. We show that this apoptosis resistance involves the selective up-regulation of the short isoforms of the caspase-8 inhibitor c-FLIP acting directly at the CD95 receptor level. Treatment with cycloheximide during CD40 activation prevents up-regulation of those c-FLIP isoforms and sensitizes ALL cells toward CD95-mediated apoptosis. We therefore propose that induction of the short c-FLIP isoforms inhibits the onset of CD95-induced apoptosis in primary CD40-stimulated ALL cells despite high CD95 expression.",
author = "Anja Troeger and Ingo Schmitz and Meinolf Siepermann and Ludmila Glouchkova and Ulrike Gerdemann and Gritta Janka-Schaub and Klaus Schulze-Osthoff and Dagmar Dilloo",
year = "2007",
language = "Deutsch",
volume = "110",
pages = "384--387",
journal = "BLOOD",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "1",

}

RIS

TY - JOUR

T1 - Up-regulation of c-FLIPS+R upon CD40 stimulation is associated with inhibition of CD95-induced apoptosis in primary precursor B-ALL.

AU - Troeger, Anja

AU - Schmitz, Ingo

AU - Siepermann, Meinolf

AU - Glouchkova, Ludmila

AU - Gerdemann, Ulrike

AU - Janka-Schaub, Gritta

AU - Schulze-Osthoff, Klaus

AU - Dilloo, Dagmar

PY - 2007

Y1 - 2007

N2 - Previous studies on apoptosis defects in acute lymphoblastic leukemia (ALL) have focused on chemotherapy-induced, primarily mitochondrial death pathways. Yet, immunologic surveillance mechanisms including sensitization to apoptotic signals mediated via the death receptor CD95 might contribute to leukemic control. Here, we show that primary B-cell precursor ALL cells from children escape from receptor-dependent cell death in 2 ways: Resting ALL blasts are protected from receptor-mediated apoptosis due to the absence of CD95 surface expression. However, even though CD40 ligation results in up-regulation of CD95, ALL blasts, unlike normal B cells, remain resistant to apoptosis. We show that this apoptosis resistance involves the selective up-regulation of the short isoforms of the caspase-8 inhibitor c-FLIP acting directly at the CD95 receptor level. Treatment with cycloheximide during CD40 activation prevents up-regulation of those c-FLIP isoforms and sensitizes ALL cells toward CD95-mediated apoptosis. We therefore propose that induction of the short c-FLIP isoforms inhibits the onset of CD95-induced apoptosis in primary CD40-stimulated ALL cells despite high CD95 expression.

AB - Previous studies on apoptosis defects in acute lymphoblastic leukemia (ALL) have focused on chemotherapy-induced, primarily mitochondrial death pathways. Yet, immunologic surveillance mechanisms including sensitization to apoptotic signals mediated via the death receptor CD95 might contribute to leukemic control. Here, we show that primary B-cell precursor ALL cells from children escape from receptor-dependent cell death in 2 ways: Resting ALL blasts are protected from receptor-mediated apoptosis due to the absence of CD95 surface expression. However, even though CD40 ligation results in up-regulation of CD95, ALL blasts, unlike normal B cells, remain resistant to apoptosis. We show that this apoptosis resistance involves the selective up-regulation of the short isoforms of the caspase-8 inhibitor c-FLIP acting directly at the CD95 receptor level. Treatment with cycloheximide during CD40 activation prevents up-regulation of those c-FLIP isoforms and sensitizes ALL cells toward CD95-mediated apoptosis. We therefore propose that induction of the short c-FLIP isoforms inhibits the onset of CD95-induced apoptosis in primary CD40-stimulated ALL cells despite high CD95 expression.

M3 - SCORING: Zeitschriftenaufsatz

VL - 110

SP - 384

EP - 387

JO - BLOOD

JF - BLOOD

SN - 0006-4971

IS - 1

M1 - 1

ER -